Loading...
Keywords
Last Name
Institution

Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.

Berman JN, Gerbing RB, Alonzo TA, Ho PA, Miller K, Hurwitz C, Heerema NA, Hirsch B, Raimondi SC, Lange B, Franklin JL, Gamis A, Meshinchi S. Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group. Leukemia. 2011 Jun; 25(6):1039-42.

View in: PubMed

collapse authors with profiles